Sign up here to receive news updates via email.
-
September 30, 2015 |
Media, Press Releases
Berg Joins U.K. Prime Minister’s Initiative, Genomics England to Sequence 100,000 Genomes
read moreBoston based biotech company to apply its analytics platform to GENE Consortium data Sep 30, 2015, 10:23 ET from Berg BOSTON, Sept. 30, 2015 /PRNewswire/ — Berg, a Boston-based biopharmaceutical company at the forefront of precision medicine, today announced it will join an industry collaboration with Genomics England. Formed by U.K. Prime Minister David Cameron, Genomics England is partnering with innovative…
-
September 8, 2015 |
Media, Press Releases
National Institutes of Health to Evaluate Berg’s Drug for the Treatment of Kidney Cancer
read moreBOSTON, Sept. 8, 2015 — Berg, a Boston-based biopharmaceutical company, has announced that it has entered into a Materials-Cooperative Research and Development Agreement (M-CRADA) with the United States National Institutes of Health (NIH) for the treatment of kidney cancer. Dr. W. Marston Linehan, Chief of Urologic Oncology at the Center for Cancer Research at the National Cancer…
-
June 1, 2015 |
Media, Press Releases
Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy
read moreJun 01, 2015, 08:00 ET from Berg BOSTON, June 1, 2015 /PRNewswire/ — Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American…
-
May 12, 2014 |
Media, Press Releases
BERG and Medical University of South Carolina Announce First of Its Kind Collaboration to Discover Lupus Biomarker
read moreResearch Partnership Will Combine Efforts of Leading Lupus Experts With BERG’s Award Winning Technology to Develop New, Targeted Therapies May 12, 2014, 10:00 ET from Berg FRAMINGHAM, Mass. and CHARLESTON, S.C., May 12, 2014 /PRNewswire/ — Berg and the Medical University of South Carolina today announced a strategic partnership, designed to identify new therapeutic pathways and potential biomarkers to treat Lupus, the…
-
February 18, 2014 |
Media, Press Releases
Berg And The Parkinson’s Institute And Clinical Center Announce Key Clinical Study Focused On Game-changing Innovations In Parkinson’s Disease Biomarker Discovery
read moreThird Phase of Collaboration Aims to Unravel Mysteries of Disease by Identifying Disease Markers and Potential New Drug Targets Feb 18, 2014, 09:15 ET from Berg FRAMINGHAM, Mass. and SUNNYVALE, Calif., Feb. 18, 2014 /PRNewswire/ — Berg and the Parkinson’s Institute and Clinical Center today announced the next phase in their ongoing partnership, focused on identifying potential biomarkers that may lead…
-
January 1, 1970 |
Media, Press Releases
Boehringer Ingelheim adds second AI partner in a month
read moreBERG will pair its Interrogative Biology® Platform with Boehringer Ingelheim’s Translational Medicine and Biomarker Expertise News provided by BERG Health May 06, 2020, 09:00 ET FRAMINGHAM, Mass., May 6, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with…
